Loading chat...

CT SB00641

Bill

Official Source

Status

Introduced

1/28/2021

Primary Sponsor

Martin Looney

Click for details

Origin

Senate

2021 General Assembly

AI Summary

  • Requires brand-name prescription drug manufacturers to sell sufficient samples to generic drug manufacturers
  • Applies to developers of generic drugs and biosimilar products seeking reference samples
  • Aims to promote competition in the prescription drug market
  • Amends Connecticut general statutes to implement the requirement
  • Introduced by Senator Looney (11th District) in the January 2021 session

Legislative Description

An Act Requiring Manufacturers Of Brand-name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

Last Action

Referred to Joint Committee on General Law

1/28/2021

Committee Referrals

General Law1/28/2021

Full Bill Text

No bill text available